MedPath

An observational controlled study on vaginal blood flow, sexual functioning, bladder and bowel function after radiation therapy following nerve-sparing radical hysterectomy for early stage cervical cancer (FIGO IA2-IIA).

Completed
Conditions
cancer of the cervix
cervical cancer
10038594
10046828
10029903
Registration Number
NL-OMON41297
Lead Sponsor
eids Universitair Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
30
Inclusion Criteria

All eligible patients: have been treated for stage IA2-IIA cervical cancer with nerve-sparing radical hysterectomy with pelvine lymfeadenectomy and post-operative radiation therapy; therapy must be completed at least 12 months before; no singn of recurrance or metastatic disease when the patiënt is included; are capable of understanding, reading and writing the Dutch language; have performance status of WHO 1-2, Karnofsky >60 and are <75 years of age.

Exclusion Criteria

Women in whom intravaginal brachy-therapy and/or concomitant chemotherapy has been administered are not included.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath